Lv1
10 积分 2025-05-06 加入
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial
4小时前
待确认
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma
11小时前
已完结
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma
11小时前
已关闭
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma
12小时前
已完结
Current use of PSMA–PET in prostate cancer management
12小时前
已完结
The relationship between 68Ga-PSMA uptake and Gleason Score and PSA levels in patients with prostate cancer
13小时前
求助中
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2天前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
2天前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
17天前
已完结
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
19天前
已完结
基于微生物发酵的人参皂苷转化研究进展
1个月前
已采纳
皖公网安备34019202002308
